SEC Form D · filed November 27, 2023
Centrexion Therapeutics Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Colin J. Hill · Boston, MADirectorSol J. Barer, Ph.D · Boston, MADirectorShawn R. Tomasello · Boston, MADirectorJoseph R. Swedish · Boston, MADirectorJames N. Campbell, M.D · Boston, MAExec · DirectorRandall M. Stevens · Boston, MAExecMichael J. Ward · Boston, MAExecJeffrey B. Kindler · Boston, MAExec · DirectorJ.C. J. Lopez, M.D · Boston, MADirectorChuck Templeton · CHICAGO, ILExec · DirectorAlcides Ferreira · Dayton, OHExecDaniel M. Agostino · LONDON, United KingdomDirectorPaul R. Malan · LONDON, United KingdomExec · DirectorDeryk I. King · LONDON, United KingdomDirectorHealthTronics Stone Solutions LLC · Round Rock, TXDirectorFarooq Abbasi · New York, NYDirectorIain R. Macleod · LONDON, United KingdomDirectorGiovanni J. Maso · New York, NYExecJean-Francois Clavier · San Francisco, CAExec · DirectorAndrew Mcloughlin · San Francisco, CADirectorHershel Mehta · La Habra, CADirectorTomaz Strgar · Sentjernej, 2AExec · DirectorJason Long · La Jolla, CADirectorHongliang Zhou · Denver, CODirectorBrandon M. Levitan · CHICAGO, ILExecGeorge Athanasiadis · San Juan, Puerto RicoDirectorAllen Kurt · VANCOUVER, British Columbia, CanadaExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗